Evidence map›Paper›PMID 32849605›Full record

ArticleFrontiers in immunology2020

Mitochondrial Signature in Human Monocytes and Resistance to Infection in

C Angélica Pérez-Hernández, Carina C Kern, Egle Butkeviciute, Elizabeth McCarthy, Hazel M Dockrell, María Maximina Bertha Moreno-Altamirano, Bruno A Aguilar-López, Gauri Bhosale, Hongyuan Wang, David Gems and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

C Angélica Pérez-HernándezLaboratorio de Inmunorregulación, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Carina C KernInstitute of Healthy Ageing and Department of Genetics, Evolution and Environment, University College London, London, United Kingdom.
Egle ButkeviciuteDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Elizabeth McCarthyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Hazel M DockrellDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
María Maximina Bertha Moreno-AltamiranoLaboratorio de Inmunorregulación, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Bruno A Aguilar-LópezLaboratorio de Inmunorregulación, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Gauri BhosaleDepartment of Cell and Developmental Biology, University College London, London, United Kingdom.
Hongyuan WangInstitute of Healthy Ageing and Department of Genetics, Evolution and Environment, University College London, London, United Kingdom.
David GemsInstitute of Healthy Ageing and Department of Genetics, Evolution and Environment, University College London, London, United Kingdom.
Michael R DuchenDepartment of Cell and Developmental Biology, University College London, London, United Kingdom.
Steven G SmithDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Francisco Javier Sánchez-GarcíaLaboratorio de Inmunorregulación, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
University College London · GBInstituto Politécnico Nacional · MXLondon School of Hygiene & Tropical Medicine · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council MR/R005850/1Wellcome Trust 098565/Z/12/ZWellcome Trust 215574Wellcome Trust 215574/Z/19/Z
6 · The paper itself

Abstract

Monocytes can develop immunological memory, a functional characteristic widely recognized as innate immune training, to distinguish it from memory in adaptive immune cells. Upon a secondary immune challenge, either homologous or heterologous, trained monocytes/macrophages exhibit a more robust production of pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, than untrained monocytes.

Indexed as

AnimalsCaenorhabditis elegansCalcium SignalingCells, CulturedCytokinesEscherichia coliEscherichia coli InfectionsFumaratesHost-Pathogen InteractionsHumansImmunity, InnateImmunologic MemoryMembrane Potential, MitochondrialMitochondriaMitochondrial DynamicsMonocytesCytokinesFumaratesC. elegansimmune traininginfectioninnate immunitymitochondriamonocytes

Identifiers

PMID32849605
PMCPMC7419614
OpenAlexW3047022544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.